ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells
Clinical and Translational Medicine2020Vol. 10(1), pp. 57–73
Citations Over TimeTop 10% of 2020 papers
Abstract
Our results highlight that inhibition of ATP7A is a potential strategy for targeting breast cancer resistant to cisplatin, and we provided an interesting method to compare the involvement of various genes in the assessment of cisplatin resistance.
Related Papers
- → Menkes Protein Contributes to the Function of Peptidylglycine α-Amidating Monooxygenase(2002)94 cited
- → The copper-transporting capacity of ATP7A mutants associated with Menkes disease is ameliorated by COMMD1 as a result of improved protein expression(2011)62 cited
- → PLEKHA5, PLEKHA6 and PLEKHA7 bind to PDZD11 to target the Menkes ATPase ATP7A to the cell periphery and regulate copper homeostasis(2021)2 cited
- The Milder Allelic Form, Occipital Horn Syndrome, in Contrast to the More Severe Form, Menkes Disease, is caused by Very Small Amounts of Normal ATP7A Transcript(2021)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)